These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 3254552)

  • 21. Measles and subacute sclerosing panencephalitis. An argument for intensified vaccination in Australia.
    Robbins SJ
    Med J Aust; 1984 Sep; 141(6):325-7. PubMed ID: 6503814
    [No Abstract]   [Full Text] [Related]  

  • 22. Subacute sclerosing panencephalitis in Papua New Guinea.
    Lucas K
    P N G Med J; 1993 Sep; 36(3):185-6. PubMed ID: 8059542
    [No Abstract]   [Full Text] [Related]  

  • 23. Subacute sclerosing panencephalitis in children: prevalence in South China.
    Ip P; Chung BH; Wong VC; Chan KY
    Pediatr Neurol; 2004 Jul; 31(1):46-51. PubMed ID: 15246492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prospects of measles and subacute sclerosing panencephalitis (SSPE) elimination in Poland].
    Naruszewicz-Lesiuk D; Wieczorkiewicz M; Iwińska-Buksowicz B; Kulczycki J
    Neurol Neurochir Pol; 1999; 33(3):653-63. PubMed ID: 10540725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subacute sclerosing panencephalitis mortality, United States, 1979-2016: Vaccine-induced declines in SSPE deaths.
    Pallivathucal LB; Noymer A
    Vaccine; 2018 Aug; 36(35):5222-5225. PubMed ID: 30057285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Epidemiology of subacute sclerosing panencephalitis in Okinawa, Japan--the second report 1977-1999].
    Hirayasu K; Nakada Y; Oshiro S; Takaesu E; Nakamura K; Shiroma N; Minema H
    No To Hattatsu; 2004 Jan; 36(1):21-5. PubMed ID: 14737859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing epidemiological features of subacute sclerosing panencephalitis.
    Anlar B; Köse G; Gürer Y; Altunbaşak S; Haspolat S; Okan M
    Infection; 2001 Aug; 29(4):192-5. PubMed ID: 11545478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Reasons for vaccinating against measles].
    Celers J; Netter R
    Bull Acad Natl Med; 1982 Jun; 166(6):801-7. PubMed ID: 6756595
    [No Abstract]   [Full Text] [Related]  

  • 29. A vaccine-preventable infectious disease kills half a million children annually.
    Katz SL
    J Infect Dis; 2005 Nov; 192(10):1679-80. PubMed ID: 16235162
    [No Abstract]   [Full Text] [Related]  

  • 30. The history of studies on subacute sclerosing panencephalitis in Poland.
    Kulczycki J
    Folia Neuropathol; 1998; 36(4):191-8. PubMed ID: 10079599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subacute Sclerosing Panencephalitis: The Foothold in Undervaccination.
    Holt RL; Kann D; Rassbach CE; Schwenk HT; Ritter JM; Rota PA; Elbers J
    J Pediatr; 2016 Dec; 179():259-262. PubMed ID: 27634625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of subacute sclerosing panencephalitis (SSPE). A report of the SSPE registry.
    Jabbour JT; Duenas DA; Sever JL; Krebs HM; Horta-Barbosa L
    JAMA; 1972 May; 220(7):959-62. PubMed ID: 4554467
    [No Abstract]   [Full Text] [Related]  

  • 33. [Evaluation of changes in the epidemiological situation of SSPE in Poland in the years 1977-1991 (in the course of 15 years after the introduction of mandatory antimeasles vaccination)].
    Naruszewicz-Lesiuk D; Kulczycki J; Iwińska-Buksowicz B; Wieczorkiewicz M; Gut W
    Neurol Neurochir Pol; 1993; 27(3):341-8. PubMed ID: 8232733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Encephalitic complications of measles in 1987].
    Celers J; Netter R
    Bull Acad Natl Med; 1989 Feb; 173(2):133-8; discussion 139. PubMed ID: 2765992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of some clinical and epidemiological data of subacute progressive sclerosing panencephalitis].
    Guseo A
    Orv Hetil; 1973; 114(29):1727-35. PubMed ID: 4721854
    [No Abstract]   [Full Text] [Related]  

  • 36. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990-2002.
    Miller C; Andrews N; Rush M; Munro H; Jin L; Miller E
    Arch Dis Child; 2004 Dec; 89(12):1145-8. PubMed ID: 15557053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan.
    Okuno Y; Nakao T; Ishida N; Konno T; Mizutani H; Fukuyama Y; Sato T; Isomura S; Ueda S; Kitamura I
    Int J Epidemiol; 1989 Sep; 18(3):684-9. PubMed ID: 2807674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Subacute sclerosing panencephalitis in Poland in the years 1990-1993. Stage V of epidemiologic studies].
    Naruszewicz-Lesiuk D; Wieczorkiewicz M; Iwińska-Buksowicz B; Kulczycki J; Gut W
    Przegl Epidemiol; 1995; 49(3):261-6. PubMed ID: 7491421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Epidemiological aspects of SSPE].
    Nihei K
    Nihon Rinsho; 2007 Aug; 65(8):1460-5. PubMed ID: 17695284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subacute Sclerosing Panencephalitis: The Devastating Measles Complication That Might Be More Common Than Previously Estimated.
    Wendorf KA; Winter K; Zipprich J; Schechter R; Hacker JK; Preas C; Cherry JD; Glaser C; Harriman K
    Clin Infect Dis; 2017 Jul; 65(2):226-232. PubMed ID: 28387784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.